Korlym (Corcept Therapeutics Inc)
Welcome to the PulseAid listing for the Korlym drug offered from Corcept Therapeutics Inc. This Progestational Hormone Receptor Antagonists [MoA],Progestin Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Corcept Therapeutics Inc |
NON-PROPRIETARY NAME: | Mifepristone |
SUBSTANCE NAME: | MIFEPRISTONE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Progestational Hormone Receptor Antagonists [MoA],Progestin Antagonist [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2012-02-17 |
END MARKETING DATE: | 0000-00-00 |
Korlym HUMAN PRESCRIPTION DRUG Details:
Item Description | Korlym from Corcept Therapeutics Inc |
LABELER NAME: | Corcept Therapeutics Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 300(mg/1) |
START MARKETING DATE: | 2012-02-17 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 76346-073_2c2f37c5-3df0-4f90-a2c9-b8a62012bdf8 |
PRODUCT NDC: | 76346-073 |
APPLICATION NUMBER: | NDA202107 |
Other MIFEPRISTONE Pharmaceutical Manufacturers / Labelers: